Welcome to our virtual exhibit booth!

Pfizer logo

About Us

At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 23 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, genitourinary, colorectal, blood and lung cancers, as well as melanoma.

Click the graphic below for more information.

Contact Us

Name: Chris Bryant
Title: Hematology Account Specialist
E-mail: chris.d.bryant@pfizer.com